• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY:JNJ)

234.18 -0.36 (-0.15%)
Official Closing Price Updated: 7:00 PM EDT, Apr 17, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 8,946,289
Open 234.36
Bid (Size) 233.60 (100)
Ask (Size) 233.85 (100)
Prev. Close 234.54
Today's Range 232.04 - 235.54
52wk Range 146.12 - 251.71
Shares Outstanding 2,628,679,824
Dividend Yield 2.22%
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Could This Healthcare Stock Help Make You Rich Over the Next Decade? ↗
Today 12:05 EDT
Intuitive Surgical has already made many of its early investors wealthy. 
Via The Motley Fool
News headline image
Is Johnson & Johnson a Buy After Its Q1 2026 Earnings Report? ↗
April 18, 2026
Solid results weren't impressive enough to move the stock price higher. 
Via The Motley Fool
Topics Intellectual Property

Performance

YTD
+12.9%
+12.9%
1 Month
-1.4%
-1.4%
3 Month
+7.3%
+7.3%
6 Month
+20.9%
+20.9%
1 Year
+49.2%
+49.2%

More News

Read More
News headline image
3 Catalysts That Could Send Teva Stock to $40 and Beyond ↗
April 18, 2026
Via The Motley Fool
News headline image
3 Under-the-Radar Healthcare Stocks Worth Adding to Your Watchlist ↗
April 16, 2026
Via The Motley Fool
News headline image
This "Boring" Dividend King Is Quietly Turning Into a Growth Machine ↗
April 16, 2026
Via The Motley Fool
News headline image
3 Healthcare Stocks That Have Held Up in Every Market Downturn ↗
April 16, 2026
Via The Motley Fool
Topics Economy
News headline image
Skip the 10-Year Bond? 3 Dividend Aristocrats to Consider Now ↗
April 16, 2026
Via MarketBeat
Topics Bonds Earnings Economy
News headline image
The Infrastructure Play Hiding in Plain Sight Across Cardiac Care
April 16, 2026
From Equity Insider
Via GlobeNewswire
News headline image
Eli Lilly Partner MeiraGTx Regains Rights For Genetic Eye Disease Drug From Johnson & Johnson ↗
April 16, 2026
Via Benzinga
News headline image
Johnson & Johnson to Participate in the Bank of America 2026 Healthcare Conference
April 15, 2026
From Johnson & Johnson
Via Business Wire
News headline image
J&J Shatters Estimates as Oncology and MedTech Power 2026 Outlook Higher
April 15, 2026
Via MarketMinute
Topics Economy Intellectual Property
News headline image
These Analysts Boost Their Forecasts On Johnson & Johnson Following Strong Q1 Results ↗
April 15, 2026
Via Benzinga
News headline image
Johnson & Johnson Posts Solid Q1 To Kickstart 'Year Of Accelerating Growth,' Says Bullish Analyst ↗
April 15, 2026
Via Benzinga
News headline image
Consolidation Fever: Boston Scientific’s $14.9 Billion Bet on Penumbra Signals New Era in MedTech M&A
April 15, 2026
Via MarketMinute
Topics Economy
News headline image
Transcript: Johnson & Johnson Q1 2026 Earnings Conference Call ↗
April 15, 2026
Via Benzinga
News headline image
Oil Drops, Dimon Warns, and the Record Is Within Reach ↗
April 15, 2026
Via Chartmill
Topics Artificial Intelligence Economy Government
News headline image
MedTech Surge and Oncology Resilience Drive Johnson & Johnson to Q1 Earnings Beat
April 14, 2026
Via MarketMinute
Topics Bankruptcy Earnings Economy
News headline image
What Makes a Healthcare Stock Worth Holding Through a Recession? ↗
April 14, 2026
Via The Motley Fool
Topics Economy
News headline image
Johnson & Johnson: A 20% Gain Looks Easy After Q1 Earnings Results ↗
April 14, 2026
Via MarketBeat
News headline image
Johnson & Johnson Q1 2026 Earnings Call Transcript ↗
April 14, 2026
Via Benzinga
Topics Earnings
News headline image
Johnson & Johnson Shatters Expectations in Q1 2026, Raising Full-Year Outlook as Healthcare Giant Pushes Toward $100 Billion Milestone
April 14, 2026
Via MarketMinute
Topics Economy Intellectual Property
News headline image
Johnson & Johnson Q1 Performance: Cancer Drug Revenue Grows, Free Cash Flow Falls, Hikes Dividend ↗
April 14, 2026
Via Benzinga
News headline image
The New J&J: A 2026 Deep Dive into the Global Healthcare Titan
April 14, 2026
Via Finterra
Topics Artificial Intelligence Death Economy
News headline image
Dow Jones' J&J Slips Despite Beating First-Quarter Calls, Hiking Guidance ↗
April 14, 2026
Via Investor's Business Daily
Topics Stocks
News headline image
Dow Jones Stocks In Spotlight: JPMorgan, Johnson & Johnson Among This Week's Earnings Reports ↗
April 13, 2026
Via Benzinga
Topics Stocks

Frequently Asked Questions

Is Johnson & Johnson publicly traded?
Yes, Johnson & Johnson is publicly traded.
What exchange does Johnson & Johnson trade on?
Johnson & Johnson trades on the New York Stock Exchange
What is the ticker symbol for Johnson & Johnson?
The ticker symbol for Johnson & Johnson is JNJ on the New York Stock Exchange
What is the current price of Johnson & Johnson?
The current price of Johnson & Johnson is 234.18
When was Johnson & Johnson last traded?
The last trade of Johnson & Johnson was at 04/17/26 07:00 PM ET
What is the market capitalization of Johnson & Johnson?
The market capitalization of Johnson & Johnson is 615.58B
How many shares of Johnson & Johnson are outstanding?
Johnson & Johnson has 616B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap